Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO)
HYMACO
Randomized, Comparative Pilot Study Evaluating the Effectiveness of autoHYpnosis by Anchoring in the Prevention of Anxiety Related to Wearing the Mask for Radiotherapy of Head and Neck Tumors
1 other identifier
interventional
60
1 country
2
Brief Summary
HYMACO is a monocentric, randomized comparative pilot study with a total duration of 25 months. The purpose of this study is to evaluate the effectiveness of autoHYpnosis by anchoring in the prevention of anxiety related to wearing the mask for radiotherapy of head and neck tumors. 60 patients will be randomized into 3 arms ARM A : Standard care ARM B : Autohypnosis ARM C : Musicotherapy This study is carried out during the first 5 radiotherapy sessions because this is decisive for the good progress of subsequent sessions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2020
CompletedStudy Start
First participant enrolled
December 16, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2025
CompletedJuly 24, 2025
December 1, 2024
4 years
December 7, 2020
July 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety
Anxiety will be assessed by the maximum value obtained on the STAI form Y-A questionnaire (state anxiety) on the following 3 measurements: on the centering scanner, at the first and 5th radiotherapy session.
5 weeks
Secondary Outcomes (6)
Anxiety
5 weeks
Conduct of radiotherapy session
5 weeks
Time required by the hypnopractor for the hypnosis session
1 hour
Receptivity of patients to hypnosis
5 weeks
Assessment of the patient's feelings
1 hour
- +1 more secondary outcomes
Study Arms (3)
ARM A : standard care
ACTIVE COMPARATORstandard care : Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care
ARM B : standard care + Autohypnosis
ACTIVE COMPARATORIn addition to the standard care, the patient will be called to learn autohypnosis during a specific consultation, with a radiotherapy manipulator trained to learn this technic. The patient will use this technic during the centering scanner and the first 5 radiotherapy sessions
ARM C : standard care + Musicotherapy
ACTIVE COMPARATORIn addition to the standard care, the patient will choose the music he want to listen from a music database (3 specific moods). The chosen music will be broadcast to the patient via a hi-fi system present in the treatment room during the centering scanner and for the first 5 radiotherapy sessions
Interventions
Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care
The patient will be called to learn autohypnosis during a specific consultation, with a radiotherapy manipulator trained to learn this technic. The patient will use this technic during the centering scanner and the first 5 radiotherapy sessions
the patient will choose the music he want to listen from a music database (3 specific moods). The chosen music will be broadcast to the patient via a hi-fi system present in the treatment room during the centering scanner and for the first 5 radiotherapy sessions
Eligibility Criteria
You may qualify if:
- Age \> or =18
- Patient to receive radiotherapy for a tumor of the head and neck, with a compression mask
- Patient who obtained a score equal to or greater than 56 on the STAI form Y-A questionnaire during the consultation with the radiotherapist before starting treatment
- Patient capable and willing to follow all study procedures in accordance with the protocol
- Patient who understood the study and gave informed consent
- Patient affiliated to a social security system
You may not qualify if:
- Contraindication to hypnosis: psychosis, schizophrenia
- Non-French speaking patient
- Significant hearing loss
- Pregnant woman, likely to be, or breastfeeding
- Persons deprived of their liberty or under guardianship (including guardianship)
- Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons
- Patient who has already received radiotherapy to the head or neck with a compression mask
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, Vandoeuvre lès Nancy, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Rémi ETIENNE
Institut de Cancérologie de Lorraine
- PRINCIPAL INVESTIGATOR
RENARD Sophie, MD
Institut de Cancérologie de Lorraine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2020
First Posted
December 17, 2020
Study Start
December 16, 2020
Primary Completion
December 11, 2024
Study Completion
February 5, 2025
Last Updated
July 24, 2025
Record last verified: 2024-12